Cost- effectiveness Analysis of Three Chemotherapy Schemes for Treatment of Advanced Non-small Cell Lung Cancer
- VernacularTitle:治疗晚期非小细胞肺癌3种化疗方案的成本-效果分析
- Author:
Yuyuan LIU
;
Minglan YIN
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
Chemotherapy scheme;
Cost-effectiveness analysis
- From:
China Pharmacy
1991;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To investigate the economic effects of three chemotherapy schemes in the treatment of non-small cell lung cancer(NSCLC).METHODS:114 cases of advanced NSCLC were randomly divided into 3 groups, group MVP, group NP and group TP. The cost effectiveness of the 3 groups were compared using pharmaceutical economics. RESULTS: 3 schemes costed 1 875.2 yuan,5 565.2 yuan and 8 369.6 yuan respectively; The effective rates were 33.2%,34.1% and 40.5% respectively. On the basis of scheme MVP, scheme NP and TP increased cost of 4 100 yuan and 889.64 yuan respectively for 1% increase in effective rate. CONCLUSION: Scheme TP is the preferred choice.
